Print page Share page

Our pipeline

Advancing clinical research programs in a number of important unmet medical needs.

More

Iclusig (ponatinib)

Our science

A unique, highly targeted approach to cancer drug discovery and development.

More

AP26113

A compelling investigational ALK inhibitor in non-small cell lung cancer.

More
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue